Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript

SA Transcripts159.12K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Journey Medical Corporation (DERM) Q4 2025 Earnings Call March 25, 2026 4:30 PM EDT Company Participants Jaclyn Jaffe - Senior Director of Corporate OperationsClaude Maraoui - Founder, President, CEO & DirectorJoseph Benesch - CFO & Corporate ControllerRamsey Alloush - COO, General Counsel & Company Secretary Conference Call Participants Scott Henry - Alliance Global Partners, Research DivisionMayank Mamtani - B. Riley Securities, Inc., Research DivisionBrandon Folkes - H.C. Wainwright & Co, LLC, Research DivisionThomas Flaten - Lake Street Capital Markets, LLC, Research Division Presentation Operator Ladies and gentlemen, thank you for standing by. Good afternoon, and welcome to Journey Medical's Full Year 2025 Financial Results and Corporate Update Conference Call. [Operator Instructions] Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A webcast replay of this call will be available approximately 1 hour after the end of the call for approximately 30 days. I would now like to turn the conference call over to Jaclyn Jaffe, the company's Senior Director of Corporate Operations. Please go ahead, Jaclyn. Jaclyn JaffeSenior Director of Corporate Operations Good afternoon, and thank you for participating in today's conference call. Joining me from Journey Medical's leadership team are: Claude Maraoui, Co-Founder, President and Chief Executive Officer; Joseph Benesch Chief Financial Officer; and Ramsey Alloush, Chief Operating Officer and General Counsel. During this call, management will be making forward-looking statements, including statements that address among other things, Journey Medical's expectations for future performance, operational results, financial condition and the receipt of regulatory approvals. Forward-looking statements involve risks and other factors that may cause actual results to differ materially from those statements. For more information about these risks, please refer to the risk factors described in Journey Medical's most recently filed periodic reports on Form